XpresSpa Signs Contract with JFK International Air Terminal LLC for COVID-19 Screening and Testing Location
Working with the
Announces Brand Launch of XpresCheck, Which Will Operate Under Company’s XpresTest Subsidiary
The Company is pleased to announce that it has signed a contract with
All COVID-19 screening and testing will be conducted by a newly launched brand, XpresCheck™, which will operate under the Company’s XpresTest® subsidiary.
The Company is also working closely with the
In addition, the Company is in discussions with other
The Company also announced the launch of XpresCheck, the operating brand under which the Company’s previously formed XpresTest subsidiary will screen and test for COVID-19. Although the JFK pilot test site will be in a newly constructed modular facility, the Company is discussing temporary conversions of existing
This press release may contain "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934. These include statements preceded by, followed by or that otherwise include the words "believes," "expects," "anticipates," "estimates," "projects," "intends," "should," "seeks," "future," "continue," or the negative of such terms, or other comparable terminology. Forward-looking statements relating to expectations about future results or events are based upon information available to
Source: XpresSpa Group, Inc.